Xinghuan Wang

63PUBLICATIONS
79CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biologyNaturopathyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (63)

|Aug 30, 2026
GSTM4 Suppresses Prostate Cancer Progression by Targeting TRIM27-mediated ACLY Ubiquitination and Lipid Metabolism.

|May 06, 2026
FBXL6 promotes bladder cancer progression by stabilizing ENO1 through K63-linked ubiquitination.

|Nov 26, 2025
YKT6 Promotes Bladder Cancer Progression by Stabilizing β-catenin Through USP7-Mediated Deubiquitination.

Sheng Tu, Wenzhi Du, Yongwen Luo

|Aug 18, 2025
Sirtuin1 mitigation of calcium oxalate nephropathy via enhancing itaconate abundance through reduction of histone trimethylation.

Xiangyang Yao, Haoran Liu, Chen Duan

|Aug 07, 2025
Safety and Immunogenicity of aerosolized adenovirus-vectored COVID-19 vaccine and intramuscular mRNA vaccine bivalent boosters: a randomized open-label clinical trial.

Shipo Wu, Jianying Huang, Busen Wang

|Jul 16, 2025
Temperature-related hospitalization burden under climate change.

Shujie Liao, Wei Pan, Li Wen

Pageof 11

Frequent Collaborators

30 joint publications

Yu Xiao

20 joint publications

Lingao Ju

17 joint publications

Kaiyu Qian

12 joint publications

Yi Zhang